The targeting TfR nanoparticles could be used for an effective therapeutic strategy against GSCs, and against non-stem tumor cells, and it would provide a promising tumoricidal strategy for treating glioma displaying MGMT promoter methylation. This evidence concerns the gene MGMT and glioma.